Advertisement
Editorial: FLOTUS—the healthcare influential we forgot

Editorial: FLOTUS—the healthcare influential we forgot

By Merrill Goozner  |  August 20, 2016

Michelle Obama during her nearly eight years in the White House succeeded in changing the national conversation about diet and exercise, and gave a major boost to transparency about the foods we eat.

Innovations: Startup's liquid biopsies match cancer patients with trials

Innovations: Startup's liquid biopsies match cancer patients with trials

By Erica Teichert  |  August 20, 2016

Guardant Health, based in Redwood City, Calif., developed a liquid biopsy blood test that has helped match cancer patients with clinical trials and treatment options without costly or invasive biopsies. CEO and co-founder Helmy Eltoukhy calls it a “game changer” for oncology.

FDA approves test of genetically modified mosquitoes in Florida

By Associated Press  |  August 06, 2016

Federal authorities gave final approval Friday to a plan to release genetically modified mosquitoes in Florida, but none of the insects will be immediately dispatched in the state's fight against the spread of Zika.

What will happen with healthcare policy under President Trump ... or ... Clinton?

What will happen with healthcare policy under President Trump ... or ... Clinton?

By Harris Meyer  |  July 23, 2016

The November elections surely won't end the nonstop, eight-year political war over the shape of the U.S. healthcare system. But the ballot results likely will determine whether the changes driven by the ACA continue in the same direction or the system returns to its previous, less-regulated form.

Long-term costs of Zika among the many unknowns of the virus

Long-term costs of Zika among the many unknowns of the virus

By Shannon Muchmore  |  July 23, 2016

History buffs and infectious-disease experts have already drawn links between the rubella outbreak in the 1960s and the current spread of Zika. But drugmakers today face greater regulatory hurdles, and the federal government has yet to dedicate funding to address the Zika epidemic.

Supply chain firms to discuss effects of UDI mandate

By Adam Rubenfire  |  July 23, 2016

A federal mandate to use unique device identifiers offers an opportunity to reduce the risk of patients being harmed by products, but the UDI system, which is being implemented over the next four years by the Food and Drug Administration, means a lot of changes— especially for the...

Abbott gains approval for first fully dissolving artery stent

Abbott gains approval for first fully dissolving artery stent

By Adam Rubenfire  |  July 05, 2016

The Food and Drug Administration has approved the first fully absorbable stent used to treat coronary artery disease. But physicians are likely to keep using metallic stents until later generations of biodegradable stents are released and more data are gathered on trial patients.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.